title: Where has all the chlamydia come from? The clinical impact of the introduction of an improved chlamydia test.
abstract: At a time of increasing demands on genitourinary (GU) medicine clinics, the introduction of a new nucleic acid test to a GU medicine clinic has the potential to increase the workload due to increased numbers of patients being identified with chlamydia, and a consequent increase in partner notification. In one clinic setting, we found a doubling in the rates of chlamydial infection following the introduction of a new test, but a concomitant reduction in the rates of non-specific genital infection. The improved specificity of the test has made counselling of patients with chlamydia and non-specific infection much easier. An audit has shown that contact-tracing outcomes are significantly better in patients who are diagnosed with chlamydia.
authors.affiliation: Department of Genitourinary Medicine, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK. jackiesherrard@doctors.org.uk
authors.forename: Jackie
authors.initials: J
authors.lastname: Sherrard
authors.forename: Margaret
authors.initials: M
authors.lastname: Rings
authors.forename: Chris
authors.initials: C
authors.lastname: Hall
mesh_terms: D000293:Adolescent; D000328:Adult; D002690:Chlamydia Infections / Q000150:complications / Q000175:diagnosis* / Q000635:transmission; D005260:Female; D006801:Humans; D008297:Male; D016526:Workload